MWNA
STJ

Marshall Wace North America’s St Jude Medical STJ Stock Holding History

Marshall Wace North America’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-245,890
Closed -$13.2M – 907
2013
Q3 		$13.2M Buy
+245,890
New +$12.7M 0.4% 72

Other funds holding STJ

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Marshall Wace North America's STJ Position: Q4 2013 in Review

Marshall Wace North America sold out of St Jude Medical (STJ) in Q4 2013, closing a stake of 245,890 shares — an estimated $13.2M sold.

Marshall Wace North America first reported a position in STJ in Q3 2013 and held it in 1 quarter. The position peaked at $13.2M in Q3 2013. 534 funds tracked by Wall St. Rank hold STJ as of Q4 2013.

  • Marshall Wace North America reported no remaining St Jude Medical position as of Q4 2013 after selling out during the quarter.
  • Marshall Wace North America sold 245,890 St Jude Medical shares in Q4 2013, an estimated $13.2M.
  • Marshall Wace North America first reported a position in St Jude Medical in Q3 2013 and held it in 1 quarter.
  • Marshall Wace North America's St Jude Medical position peaked at $13.2M in Q3 2013.
  • 534 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2013.

Based on Marshall Wace North America's 13F filing for Q4 2013, filed 14 Feb 2014.